Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79826 - 79850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Toluene	Investigational Vet Approved	ZCCHC2	54877	upregulated	Toluene results in increased expression of ZCCHC2 mRNA	18q21.33	A24445
Topiramate	Approved Investigational	CYP3A4	1576	upregulated	topiramate results in increased expression of CYP3A4 mRNA	7q22.1	A24057
Topotecan	Approved Investigational	BCL2	596	downregulated	Topotecan results in decreased expression of BCL2 mRNA	18q21.33	A23208
Topotecan	Approved Investigational	BCL2L12	83596	downregulated	Topotecan results in decreased expression of BCL2L12 mRNA	19q13.33	A23208
Topotecan	Approved Investigational	EGFR	1956	downregulated	Topotecan results in decreased expression of EGFR mRNA	7p11.2	A24449
Topotecan	Approved Investigational	FAS	355	downregulated	Topotecan results in decreased expression of FAS mRNA	10q23.31	A23208
Topotecan	Approved Investigational	MGMT	4255	downregulated	Topotecan results in decreased expression of MGMT mRNA	10q26.3	A21502
Topotecan	Approved Investigational	TOP2A	7153	downregulated	Topotecan results in decreased expression of TOP2A mRNA	17q21.2	A22483
Topotecan	Approved Investigational	TREX1	11277	upregulated	Topotecan results in increased expression of TREX1 mRNA	3p21.31	A21557
Torcetrapib	Investigational	AASDHPPT	60496	upregulated	torcetrapib results in increased expression of AASDHPPT mRNA	11q22.3	A24450
Torcetrapib	Investigational	AFF2	2334	upregulated	torcetrapib results in increased expression of AFF2 mRNA	Xq28	A24450
Torcetrapib	Investigational	AGPAT3	56894	upregulated	torcetrapib results in increased expression of AGPAT3 mRNA	21q22.3	A24450
Torcetrapib	Investigational	AHCTF1	25909	upregulated	torcetrapib results in increased expression of AHCTF1 mRNA	1q44	A24450
Torcetrapib	Investigational	AKIRIN1	79647	upregulated	torcetrapib results in increased expression of AKIRIN1 mRNA	1p34.3	A24450
Torcetrapib	Investigational	AKT2	208	upregulated	torcetrapib results in increased expression of AKT2 mRNA	19q13.2	A24450
Torcetrapib	Investigational	AKT3	10000	upregulated	torcetrapib results in increased expression of AKT3 mRNA	1q43-q44	A24450
Torcetrapib	Investigational	AMMECR1	9949	upregulated	torcetrapib results in increased expression of AMMECR1 mRNA	Xq23	A24450
Torcetrapib	Investigational	AMOTL1	154810	upregulated	torcetrapib results in increased expression of AMOTL1 mRNA	11q21	A24450
Torcetrapib	Investigational	AMZ2P1	201283	upregulated	torcetrapib results in increased expression of AMZ2P1 mRNA	17q24.1	A24450
Torcetrapib	Investigational	ANGPT1	284	upregulated	torcetrapib results in increased expression of ANGPT1 mRNA	8q23.1	A24450
Torcetrapib	Investigational	ANK3	288	upregulated	torcetrapib results in increased expression of ANK3 mRNA	10q21.2	A24450
Torcetrapib	Investigational	ANKRD11	29123	upregulated	torcetrapib results in increased expression of ANKRD11 mRNA	16q24.3	A24450
Torcetrapib	Investigational	ANXA1	301	upregulated	torcetrapib results in increased expression of ANXA1 mRNA	9q21.13	A24450
Torcetrapib	Investigational	AP3D1	8943	upregulated	torcetrapib results in increased expression of AP3D1 mRNA	19p13.3	A24450
Torcetrapib	Investigational	APBB2	323	upregulated	torcetrapib results in increased expression of APBB2 mRNA	4p14-p13	A24450

Displaying entries 79826 - 79850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability